Skip navigation

Refine by Type

Results 1 - 10 of 12 for ponatinib
  1. Ponatinib is used to treat a certain type of chronic myeloid leukemia (CML; a type of cancer ... cannot take these medications because of side effects. Ponatinib is also used to treat a certain type ...
  2. ... to use a birth control method during treatment. Ponatinib (brand name: Iclusig) — Ponatinib is another TKI that may be recommended for ... T315I). Due to concerns regarding dangerous side effects, ponatinib is reserved for use in patients who are ...
  3. Drugs Approved for Leukemia From the National Institutes of Health (National Cancer Institute)  
    ... Methotrexate) Folex PFS (Methotrexate) Gleevec (Imatinib Mesylate) Iclusig (Ponatinib Hydrochloride) Imatinib Mesylate Marqibo (Vincristine Sulfate Liposome) Mercaptopurine ...
  4. CML Guide: Information for Patients and Caregivers (Leukemia & Lymphoma Society) - PDF  
    ... are intolerant of or resistant to Gleevec. { { Bosutinib* { { Ponatinib (AP24534)* { { Interferon (Intron A®, Roferon-A®) { { Peginterferon alfa-2a ( ...
  5. Cancer Drug Information From the National Institutes of Health (National Cancer Institute)  
    ... to Top I Ibritumomab Tiuxetan Ibrutinib ICE Iclusig (Ponatinib Hydrochloride) Ifex (Ifosfamide) Ifosfamide Ifosfamidum (Ifosfamide) Imatinib Mesylate ... Cisplatin) Platinol-AQ (Cisplatin) Plerixafor Pomalidomide Pomalyst (Pomalidomide) Ponatinib ... Hydrochloride Proleukin (Aldesleukin) Prolia ( ...
  6. Index to Drug-Specific Information (Food and Drug Administration)  
    ... hydrochlorothiazide) back to top I Ibandronate Ibuprofen Iclusig (ponatinib) Imatinib mesylate Iplex Incivek Infliximab Imitrex (sumatriptan) Innohep ( ... Placidyl (ethchlorvynol) Plan B (levonorgestrel) Plavix (clopidogrel ... (ezogabine) Pradaxa (dabigatran etexilate mesylate) Pramipexole Pregabalin ...
  7. Snapshot of Leukemia From the National Institutes of Health (National Cancer Institute)  
    ... In a phase I trial , the experimental drug ponatinib showed promising activity in patients with tyrosine kinase ...
  8. Targeted Therapy (American Cancer Society)  
    ... Gleevec ® ), dasatinib (Sprycel ® ), nilotinib (Tasigna ® ), bosutinib (Bosulif ® ), and ponatinib (Iclusig ™ ). Although these drugs were mainly aimed at ...
  9. Facts 2013 (Leukemia & Lymphoma Society) - PDF  
    ... 60 days of completion of the last therapy. Ponatinib (Iclusig ® ) is approved to treat adult patients with ...
  10. Leukemia Trial Results From the National Institutes of Health (National Cancer Institute)  
    ... Posted: 12/17/2012) - A new drug called ponatinib may be a new treatment option for patients ...
previous · 1 · 2 · next